Auto-Threshold quantification of late gadolinium enhancement in patients with acute heart disease

Journal of Magnetic Resonance Imaging

Volumn 37, Issue 2, 2013, Pages 382-390

  Vermes, Emmanuelle ^a   Childs, Helene ^a   Carbone, Iacopo ^a   Barckow, Philipp ^b   Friedrich, Matthias G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b Circle Cardiovascular Imaging Inc ^*  (Canada)

Author keywords

cardiovascular magnetic resonance; myocardial infarction; myocarditis

Indexed keywords

GADOLINIUM PENTETATE;

ACUTE HEART INFARCTION; ALGORITHM; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HEART DISEASE; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HUMAN; INTERMETHOD COMPARISON; LATE GADOLINIUM ENHANCEMENT; MAJOR CLINICAL STUDY; MYOCARDITIS; OTSU AUTO THRESHOLD; PRIORITY JOURNAL; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ACUTE DISEASE; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL ISCHEMIA; MYOCARDITIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84872918244     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23814     Document Type: Article

References (25)

1. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453.
2. Bogaert J, Kalantzi M, Rademakers FE, Dymarkowski S, Janssens S,. Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging. Eur Radiol 2007; 17: 2572-2580.
3. Larose E, Rodés-Cabau J, Pibarot P, et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction. J Am Coll Cardiol 2010; 55: 2459-2469.
4. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005; 45: 1815-1822. (Pubitemid 40779862)
5. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004; 109: 1250-1258. (Pubitemid 38379570)
6. Laissy JP, Hyafil F, Feldman LJ, et al. Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology 2005; 237: 75-82. (Pubitemid 41346148)
7. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 2009; 53: 1475-1487.
8. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA,. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001; 104: 2838-2842. (Pubitemid 33126660)
9. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM,. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36: 1985-1991.
10. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002. (Pubitemid 29529292)
11. Bondarenko O, Beek AM, Hofman MB, et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005; 7: 481-485. (Pubitemid 40563339)
12. Beek AM, Bondarenko O, Afsharzada F, van Rossum AC,. Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome. J Cardiovasc Magn Reson 2009; 11: 6.
13. Heiberg E, Ugander M, Engblom H, et al. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology 2008; 246: 581-588.
14. Amado LC, Gerber BL, Gupta SN, et al. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004; 44: 2383-2389. (Pubitemid 39647614)
15. Hsu LY, Natanzon A, Kellman P, Hirsch GA, Aletras AH, Arai AE,. Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006; 23: 298-308. (Pubitemid 43364055)
16. Flett AS, Hasleton J, Cook C, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 2011; 4: 150-156.
17. Otsu N,. A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cyberb 1979; 9: 62-66. (Pubitemid 9413341)
18. Eitel I, Desch S, Fuernau G, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 2010; 55: 2470-2479.
19. Larose E, Rodes-Cabau J, Pibarot P, et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol 2010; 55: 2459-2469.
20. Beek AM, Kuhl HP, Bondarenko O, et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003; 42: 895-901. (Pubitemid 37059750)
21. Spiewak M, Malek LA, Misko J, et al. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Eur J Radiol 2009; 74: e149-153.
22. Zagrosek A, Abdel-Aty H, Boye P, et al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2009; 2: 131-138.
23. Cocker MS, Abdel-Aty H, Strohm O, Friedrich MG,. Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study. Heart 2009; 95: 1925-1930.
24. Korkusuz H, Esters P, Huebner F, Bug R, Ackermann H, Vogl TJ,. Accuracy of cardiovascular magnetic resonance in myocarditis: comparison of MR and histological findings in an animal model. J Cardiovasc Magn Reson 2010; 12: 49.
25. Baccouche H, Mahrholdt H, Meinhardt G, et al. Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J 2009; 30: 2869-2879.